RASSF1 and non-small cell lung carcinoma: By using either RNAi to mimic RASSF1A methylation in NSCLC or RASSF1A-encoding plasmid in rescue experiments, this study provided molecular insights into the prognostic value of RASSF1A and how its depletion would possibly affect the efficiency of chemotherapeutic agents like paclitaxel and gemcitabine.